Antonio Passaro: Our editorial on the groundbreaking ALINA trial

Antonio Passaro, Medical Oncologist at European Institute of Oncology, shared on X/Twitter:

“Just published in NEJM our editorial on the groundbreaking ALINA trial, evaluating the role of adjuvant alectinib in patients with resected NSCLC carrying ALK rearrangements. A major advance for our patients!”